annual CFI:
$44.18M+$220.92M(+125.00%)Summary
- As of today (May 21, 2025), PTCT annual cash flow from investing activities is $44.18 million, with the most recent change of +$220.92 million (+125.00%) on December 31, 2024.
- During the last 3 years, PTCT annual CFI has fallen by -$175.00 million (-79.84%).
- PTCT annual CFI is now -84.77% below its all-time high of $290.18 million, reached on December 31, 2022.
Performance
PTCT Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$184.36M-$452.07M(-168.87%)Summary
- As of today (May 21, 2025), PTCT quarterly cash flow from investing activities is -$184.36 million, with the most recent change of -$452.07 million (-168.87%) on March 1, 2025.
- Over the past year, PTCT quarterly CFI has dropped by -$69.43 million (-60.41%).
- PTCT quarterly CFI is now -168.87% below its all-time high of $267.71 million, reached on December 31, 2024.
Performance
PTCT quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$25.25M-$69.43M(-157.14%)Summary
- As of today (May 21, 2025), PTCT TTM cash flow from investing activities is -$25.25 million, with the most recent change of -$69.43 million (-157.14%) on March 1, 2025.
- Over the past year, PTCT TTM CFI has increased by +$237.45 million (+90.39%).
- PTCT TTM CFI is now -107.74% below its all-time high of $326.02 million, reached on September 30, 2022.
Performance
PTCT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
PTCT Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +125.0% | -60.4% | +90.4% |
| 3 y3 years | -79.8% | -475.9% | -110.6% |
| 5 y5 years | +111.4% | -82.0% | +92.5% |
PTCT Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -84.8% | +125.0% | -168.9% | at low | -107.7% | +92.1% |
| 5 y | 5-year | -84.8% | +107.9% | -168.9% | +53.2% | -107.7% | +95.7% |
| alltime | all time | -84.8% | +107.9% | -168.9% | +53.2% | -107.7% | +95.7% |
PTCT Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$184.36M(-168.9%) | -$25.25M(-157.1%) |
| Dec 2024 | $44.18M(-125.0%) | $267.71M(-727.3%) | $44.18M(-113.9%) |
| Sep 2024 | - | -$42.67M(-35.3%) | -$317.95M(+4.3%) |
| Jun 2024 | - | -$65.92M(-42.6%) | -$304.87M(+16.1%) |
| Mar 2024 | - | -$114.93M(+21.7%) | -$262.70M(+48.6%) |
| Dec 2023 | -$176.74M(-160.9%) | -$94.42M(+219.0%) | -$176.74M(+254.3%) |
| Sep 2023 | - | -$29.60M(+24.6%) | -$49.88M(-142.9%) |
| Jun 2023 | - | -$23.75M(-18.0%) | $116.16M(-45.3%) |
| Mar 2023 | - | -$28.97M(-189.3%) | $212.17M(-26.9%) |
| Dec 2022 | $290.18M(+32.4%) | $32.44M(-76.2%) | $290.18M(-11.0%) |
| Sep 2022 | - | $136.44M(+88.8%) | $326.02M(+28.2%) |
| Jun 2022 | - | $72.25M(+47.3%) | $254.28M(+6.8%) |
| Mar 2022 | - | $49.04M(-28.2%) | $238.08M(+8.6%) |
| Dec 2021 | $219.18M(-139.0%) | $68.27M(+5.5%) | $219.18M(-483.1%) |
| Sep 2021 | - | $64.70M(+15.4%) | -$57.21M(-88.9%) |
| Jun 2021 | - | $56.06M(+85.9%) | -$516.13M(+20.0%) |
| Mar 2021 | - | $30.15M(-114.5%) | -$430.13M(-23.4%) |
| Dec 2020 | -$561.55M(+45.0%) | -$208.12M(-47.2%) | -$561.55M(-3.6%) |
| Sep 2020 | - | -$394.21M(-377.5%) | -$582.42M(+269.1%) |
| Jun 2020 | - | $142.06M(-240.3%) | -$157.78M(-53.3%) |
| Mar 2020 | - | -$101.27M(-55.8%) | -$338.01M(-12.7%) |
| Dec 2019 | -$387.24M(+808.7%) | -$229.00M(-852.6%) | -$387.24M(+111.8%) |
| Sep 2019 | - | $30.43M(-179.7%) | -$182.84M(-23.0%) |
| Jun 2019 | - | -$38.17M(-74.6%) | -$237.38M(+24.0%) |
| Mar 2019 | - | -$150.50M(+511.9%) | -$191.46M(+349.3%) |
| Dec 2018 | -$42.61M | -$24.60M(+2.0%) | -$42.61M(-40.9%) |
| Sep 2018 | - | -$24.11M(-411.4%) | -$72.06M(+151.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | $7.74M(-569.9%) | -$28.67M(+121.4%) |
| Mar 2018 | - | -$1.65M(-97.0%) | -$12.95M(-198.7%) |
| Dec 2017 | $13.12M(-87.4%) | -$54.04M(-380.4%) | $13.12M(-85.5%) |
| Sep 2017 | - | $19.27M(-17.9%) | $90.29M(-17.4%) |
| Jun 2017 | - | $23.47M(-3.9%) | $109.25M(+2.3%) |
| Mar 2017 | - | $24.42M(+5.6%) | $106.78M(+2.2%) |
| Dec 2016 | $104.48M(-602.0%) | $23.13M(-39.5%) | $104.48M(+253.9%) |
| Sep 2016 | - | $38.24M(+82.1%) | $29.52M(-296.8%) |
| Jun 2016 | - | $21.00M(-5.1%) | -$15.00M(-22.3%) |
| Mar 2016 | - | $22.12M(-142.7%) | -$19.30M(-7.3%) |
| Dec 2015 | -$20.81M(-85.7%) | -$51.83M(+724.8%) | -$20.81M(-74.7%) |
| Sep 2015 | - | -$6.28M(-137.6%) | -$82.17M(+198.7%) |
| Jun 2015 | - | $16.70M(-19.0%) | -$27.50M(-77.1%) |
| Mar 2015 | - | $20.61M(-118.2%) | -$120.29M(-17.1%) |
| Dec 2014 | -$145.17M(+13.6%) | -$113.19M(-334.0%) | -$145.17M(+455.9%) |
| Sep 2014 | - | $48.38M(-163.6%) | -$26.11M(-86.7%) |
| Jun 2014 | - | -$76.09M(+1683.3%) | -$196.51M(+48.8%) |
| Mar 2014 | - | -$4.27M(-172.7%) | -$132.07M(+3.3%) |
| Dec 2013 | -$127.83M(>+9900.0%) | $5.87M(-104.8%) | -$127.83M(-4.4%) |
| Sep 2013 | - | -$122.02M(+946.5%) | -$133.70M(+1043.8%) |
| Jun 2013 | - | -$11.66M(>+9900.0%) | -$11.69M(>+9900.0%) |
| Mar 2013 | - | -$21.00K(+281.8%) | -$51.60K(-72.7%) |
| Dec 2012 | -$189.00K(-100.7%) | -$5500.00(+27.9%) | -$189.00K(+3.0%) |
| Sep 2012 | - | -$4300.00(-79.3%) | -$183.50K(+2.4%) |
| Jun 2012 | - | -$20.80K(-86.9%) | -$179.20K(+13.1%) |
| Mar 2012 | - | -$158.40K | -$158.40K |
| Dec 2011 | $27.70M | - | - |
FAQ
- What is PTC Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for PTC Therapeutics?
- What is PTC Therapeutics annual CFI year-on-year change?
- What is PTC Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for PTC Therapeutics?
- What is PTC Therapeutics quarterly CFI year-on-year change?
- What is PTC Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for PTC Therapeutics?
- What is PTC Therapeutics TTM CFI year-on-year change?
What is PTC Therapeutics annual cash flow from investing activities?
The current annual CFI of PTCT is $44.18M
What is the all time high annual CFI for PTC Therapeutics?
PTC Therapeutics all-time high annual cash flow from investing activities is $290.18M
What is PTC Therapeutics annual CFI year-on-year change?
Over the past year, PTCT annual cash flow from investing activities has changed by +$220.92M (+125.00%)
What is PTC Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of PTCT is -$184.36M
What is the all time high quarterly CFI for PTC Therapeutics?
PTC Therapeutics all-time high quarterly cash flow from investing activities is $267.71M
What is PTC Therapeutics quarterly CFI year-on-year change?
Over the past year, PTCT quarterly cash flow from investing activities has changed by -$69.43M (-60.41%)
What is PTC Therapeutics TTM cash flow from investing activities?
The current TTM CFI of PTCT is -$25.25M
What is the all time high TTM CFI for PTC Therapeutics?
PTC Therapeutics all-time high TTM cash flow from investing activities is $326.02M
What is PTC Therapeutics TTM CFI year-on-year change?
Over the past year, PTCT TTM cash flow from investing activities has changed by +$237.45M (+90.39%)